THE IMMUNE SYSTEM can kill tumour cells or inhibit their growth in a variety of ways, including antibody and complement (Old et al., 1967) , lysis by contact with immune T-lymphocytes (Cerottini and Brunner, 1974) , antibody-dependent cell-mediated cytotoxicity (Perlmann and Holm, 1969) , contact with armed macrophages (Evans and Alexander, 1971 ) and incubation with soluble products, such as lymphotoxin, a mediator released into the supernatant when sensitized lymphocytes are incubated with antigen (Eifel, Walker and Lucas, 1975 ) and a cytotoxic factor liberated from activated macrophages (Sethi and Brandis, 1975; Currie and Basham, 1975) . To this list we add another mechanism, action of the complement cleavage product C3a.
When complement is activated, by either the classical or the alternative pathway, C3 is cleaved into a small piece, C3a, and a large piece, C3b. C3a, one of the anaphylatoxins, induces the selective release of histamine from mast cells (Dias da Silva, Eisele and Lepow, 1967; Cochrane and Miiller-Eberhard, 1968) and contraction of smooth muscle via histamine, as well as probably by a direct interaction with the muscle cell plasma membrane (Bokisch and Miiller-Eberhard, 1970) . In a recent investigation of the effects of complement cleavage products on macrophages in culture, we observed that purified C3b induces enzyme release from these cells without loss of viability, whereas incubation with even low concentrations of C3a results in death of the cells (Schorlemmer, Davies and Allison, 1976; . This observation prompted an investigation of the effects of C3a on murine and human lymphocytes and tumour cells and lymphoblastic cells in culture, which has shown that C3a in low concentrations has cytotoxic effects on a variety of normal and malignant cells.
MATERIALS AND METHODS
Preparation of complement components.-Guinea-pig C3 and the cleavage product C3b were prepared as previously reported (BitterSuermann et al., 1970; Nicholson et al., 1975) . For generation and purification of C3a, highly purified C3 was cleaved by trypsin (1 mg/ml) and, 1 min later, the reaction was stopped by addition of soybean trypsin inhibitor (4 mg/ ml). In other experiments, C3 was incubated with the C3 cleavage complex which is formed when cobra venom factor interacts with factor B, factor D and Mg++. In both cases the reaction mixtures were passed through Sephadex G100 columns. The fractions which mediated contraction of isolated guinea-pig terminal ileum were pooled and concentrated. Cobra venom factor (CVF) was purified by the method of Bitter-Suermann et al. (1972) Todaro and Green (1963) ; the C-243 line, originating from an agar colony of D55 cells transformed by murine sarcoma virus (MSV) (Bassin, Tuttle and Fischinger, 1970) ; lympb node cells obtained from mesenteric lymph nodes of BALB/c mice; Chang cells, a human liver epithelial-like cell line (Chang, 1954) ; and CLA-4 cells, a human B-lymphoid cell line (Steel, 1972) . Human peripheral blood lymphocytes were from buffy coat residues left after platelet removal from normal human blood. Lymphocytes were separated by Ficoll-Triosil density-gradient, centrifugation (Boyum, 1968) . They were cultured in RPMI 1640 medium with 10% foetal bovine serum, at a concentration of 7-5 x 105/ml and stimulated with 1 ,ug/ml of purified phytohaemagglutinin (Wellcome) (PHA) for 4 days.
The above cell lines were maintained in the same medium.
Labelling of cells.-The lysis of the cells was assessed by the release of radioactive chromium from the labelled cells by the method of Brunner et al. (1970) Cytotoxicity assay.-In the cytotoxicity tests 3-5 x 104 cells in 0 1 ml medium were mixed with various concenltrations of C3 products in 0-02 ml medium in round-bottom plastic tubes (7 5 x 1 cm) and the tubes gassed with air containing 5% CO2. After incubation at 37°C for the indicated times, 1 ml of Eagle's basal medium with 5% foetal bovine serum was added to the tubes, the cells centrifuged, and 0*5-ml samples of the supernatants taken for counting of radioactivity. The percent specific release of the labels from the cells produced by C3 derivatives, was calculated as follows: Label released in the presence of the agent -label released in its absence x 100
Total label incorporated -label released in the absence of the agent The percentage of the labels released by freezing and thawing the cells twice is indicated in the figures. Where stated, the amounts of the labels released by freezing were used, instead of the total incorporated, for the calculation of percent release. The values presented are means of duplicates and the range of variation is indicated. Spontaneous Cr release in the absence of added agents ranged between 6 and 26%, depending on the target cell type.
RESULTS

Cytolytic effect of C3a on various cell types
In several independent experiments, various types of cell were tested for their susceptibility to C3a, prepared by trypsin cleavage of the complement component C3. Fig. 1 cell types of human origin are presented. C3a lysed CLA-4 cells and Chang cells to the same extent as lymphocytes stimulated with PHA, which were also completely lysed, whereas non-stimulated lymphocytes proved to be much more resistant.
Effects of C3 and two of itscleavage products,
C3b and C3a
In further experiments, purified native C3, as well as its cleavage products C3a and C3b, were tested on mastocytoma cells. C3a was prepared by two different methods, employing trypsin or cobra venom factor, respectively. Cobra venom factor itself was also included as a control. As shown in Fig. 3 , only C3a was found to be cytolytic, and the products prepared by the two methods did not differ appreciably in their activity. An indication of This would indicate that the lysis is due to osmotic effects, as appears to be the case with complement lysis and T-lymphocyte-mediated lysis (Burakoff, Martz and Benacerraf, 1975; Ferluga and Allison, 1974) . The time dependence of the release of 864b and 51Cr in mastocytoma cells incubatAd with C3a is illustrated in ,tg/ml C3a at 370C for 1 h, showed nearly complete release of both markers. The release of both markers was much less in cells kept at 9°C for i h. However, when the cells were incubated with C3a at 3700 for 7-5 min, and then kept at 90C for the remainder of the hour, a high proportion of both labels was still released. These results suggest that, in cells maintained at relatively low temperature, C3a is unable to exert its lytic effect. Nevertheless, brief exposure of the cells to 03a at higher temperature increases the permeability of the membrane in such a way that a subsequent fall in temperature cannot reverse it. The effect of temperature on (0) guinea-pig serum, from which our C3a was derived, was tested for its effect on lysis mediated by C3a. In the presence of fresh guinea-pig serum, the lytic effect of 2'8 ,ug C3a was reduced to about a quarter of that observed in the absence of serum, and there was nearly a complete inhibition with lower doses of C3a (Table  II) . If an enzyme were involved in inactivation of C3a, it would be expected that incubation of C3a with serum for 3 h at 370C would result in further reduction of its cytolytic capacity. However, such preincubation in 50% serum resulted in less inhibition of cytolysis. Similar results were obtained in other experiments. They 18-4±0(73*8)t 33-7±2.5(51.5) 72-9±1-8 71-7±1-2 2-8±0-1 (95-9) 8-3±0-6 (87.6) 69-9±2-0 63-6±1,-5 0-5±0-1 (90.4) 2-7±0-1 (55.7) 14-2±0-5 16-8±0-4 13-2±0-2 14-2±0-2 13-1±0-2 2 -8, 1 * 4 or 0 7 ,ug of C3a in 20 ,1l RPMI medium were mixed with 20 ,ul of fresh guinea-pig serum, to which 100 ,ll of 51Cr-labelled mastocytoma cell suspension was added, either immediately or after preincubating the C3a-serum mixtures at 37°C for 3 h, and the samples incubated for 1 h in the cytotoxicity test. Tubes for control and serum samples were rinsed with 0 -1 % BSA.
* Preincubation time (h).
t Numbers in parentheses, % inhibition by serum.
Label released by freezing and thawing, 72 2 ± -3 %.
suggest that, if C3a is modified by the action of serum enzymes (e.g. carboxypeptidase B), it is converted to a derivative or derivatives which are still cytolytic. In any case, the presence of even high concentrations of serum does not abolish the capacity of C3a to lyse tumour cells.
DISCUSSION
These results establish that the complement cleavage product C3a is lytic for all the cell types tested, including several transformed cells of human and mouse origin. Our previous work established that incubation with C3a kills mouse and guineapig macrophages, so the cytolytic effect may be exerted against a wide range of cell types. The lysis by C3a is highly efficient, concentrations of 1 to 10 ,ug/ml killing the majority of exposed cells. All the cells tested were sensitive to some degree, although normal human lymphocytes were relatively resistant. Macrophages show intermediate sensitivity to lysis by C3a. Hence, if small amounts of C3a were generated (1-10 jtbg/ml) tumour cells would be lysed, while macrophages and lymphocytes would be spared. Such differential effects could be important in immunity against tumours.
The concentration of C3a required for cytolysis is somewhat less than that reported to be required for mast cell degranulation (calculated from data of Cochrane and Miiller-Eberhard, 1968 ). C3a-mediated mast cell degranulation occurs in vivo (Lepow et al., 1970) , so it is reasonable to suppose that the concentrations of C3a generated in vivo could have tumorolytic effects. Indeed, C3 circulates in large quantities (1.23 mg/ml), and if all were converted to C3a, the total amount in human plasma would be of the order of 50 ,tg/ml (Kohler and Muller-Eberhard, 1967) . It is reported that C3a is inactivated by carboxypeptidase B which is present in serum (Bokisch and MullerEberhard, 1970) . However, once the carboxy-terminal of C3a had reacted with membrane constituents, it would presumably be inaccessible to carboxypeptidase. In our experiments, incubation of C3a with fresh serum did not abolish its capacity to lyse cells, possibly because a cleavage product of C3a is still cytolytic.
The generation of C3a could be through the classical or alternative pathways of complement activation, or through enzymatic cleavage of C3 by products of activated macrophages .
Tumour cells release proteinases, including plasminogen activator (Rifkin et al., 1974) ; the active enzyme produced, plasmin, is known to cleave C3, with liberation of C3a (Bokisch, Muller-Eberhard and Cochrane, 1969 C5a, the classical anaphylatoxin, for its possible cytolytic effect, since it is also a basic polypeptide with very similar biological properties to that of C3a (Lieflander et al., 1972) . It is possible that C3a is the same as certain soluble factors which have rapid cytolytic effects, e.g. cytotoxic products from activated macrophages (Sethi and Brandis, 1975; Currie and Basham, 1975 al., 1974) . The structure of C3a is known (Hugli, 1975) : the polypeptide chain has an unusually cationic C-terminal region. The structure is that of an amphipathic molecule, which could become partially inserted into a membrane, with its Cterminal region interacting ionically with acidic glycoproteins and possibly glycolipids. Our observations show that incubation of cells with C3a makes their plasma membranes more permeable to ions such as Rb+, an analogue of K+ using the samne active transport system.
If there is also increased influx of Na+ in excess of the active transport system, osmotic lysis would result. The fact that 86Rb+ is released from cells before 51(Cr even by a relatively short interval, is consistent with osmotic lysis.
When cells are maintained in the presence of C3a at 9°C, there is little lysis, perhaps because C3a is unable to penetrate the membrane, which is rather rigid at that temperature; it is known that at 37-40°C membrane lipids are predominantly in a liquid phase, whereas at 9-10°C they are more closely packed in a regular hexagonal array (Engelman, 1970) . When mastocytoma cells have been incubated in the presence of C3a for a few minutes at 37°C and then transferred to 9°C, loss of 86Rb and 51Cr continues, suggesting that once C3a is inserted on to the membrane, the increased ion flux cannot be reversed at low temperature. In contrast, the increased ion permeability produced in mastocytoma cells by Tlymphocytes was reversed at 10°C (Ferluga and Allison, 1974) . Hence the two membrane lesions appear to be different. 
